Results
2610
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,610 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$154.69 | 2.3% | -2.1% | US$369.5b | US$168.64 | PE26.5x | E8.4% | 3.2% | Pharmaceuticals & Biotech | ||
AZN | UK£111.26 | -0.9% | 6.1% | UK£171.0b | UK£138.40 | PE33.2x | E16.9% | 2.0% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.27 | -1.1% | 31.8% | UK£145.7b | UK£8.75 | PB0.9x | E-0.9% | 5.9% | Banks | ||
CBA | AU$158.57 | -0.3% | 38.4% | AU$265.1b | AU$101.65 | PB3.6x | E4.4% | 2.9% | Banks | ||
LOW | US$258.47 | -1.2% | 16.6% | US$145.2b | US$282.24 | PE21.3x | E5.7% | 1.8% | Retail | ||
COP | US$100.21 | -1.3% | -10.8% | US$130.1b | US$131.97 | PE13.1x | E1.6% | 3.7% | Energy | ||
BHP | AU$40.26 | 2.0% | -13.3% | AU$204.2b | AU$44.32 | PE16.2x | E6.4% | 5.8% | Materials | ||
TD | CA$82.25 | -0.7% | 3.1% | CA$143.5b | CA$86.80 | PB1.3x | E11.5% | 5.1% | Banks | ||
IBKR | US$233.45 | 10.5% | 147.2% | US$93.6b | US$225.80 | PE33.7x | E2.6% | 0.4% | Diversified Financials | ||
INVE A | SEK 308.10 | -1.7% | 25.3% | SEK 938.8b | SEK 331.50 | PE8.3x | E-48.3% | 1.7% | Diversified Financials | ||
BP. | UK£4.24 | 1.8% | -10.7% | UK£66.2b | UK£4.78 | PE30.6x | E23.6% | 5.8% | Energy | ||
ATCO A | SEK 184.80 | 1.5% | 9.5% | SEK 868.9b | SEK 188.52 | PE30.2x | E6.9% | 1.6% | Capital Goods | ||
NAB | AU$39.39 | -0.3% | 22.6% | AU$120.7b | AU$34.11 | PB2x | E2.0% | 4.3% | Banks | ||
ITW | US$254.24 | -0.8% | 0.06% | US$75.2b | US$264.04 | PE21.5x | E2.5% | 2.4% | Capital Goods | ||
1299 | HK$53.25 | -1.8% | -15.3% | HK$566.9b | HK$93.02 | PE15.1x | E13.7% | 3.1% | Insurance | ||
BREN | Rp8,850.00 | -7.8% | 63.9% | Rp1184.0t | n/a | PE666x | n/a | 0.05% | Utilities | ||
WBC | AU$33.28 | -0.8% | 37.1% | AU$114.1b | AU$28.90 | PB1.6x | E-0.007% | 4.6% | Banks | ||
GSK | UK£14.85 | 6.0% | -11.2% | UK£56.3b | UK£17.94 | PE24.1x | E22.5% | 3.9% | Pharmaceuticals & Biotech | ||
CRH | US$101.16 | 2.1% | 35.4% | US$66.7b | US$114.33 | PE19.8x | E9.6% | 1.4% | Materials | ||
SPG | US$179.11 | 3.2% | 24.9% | US$65.4b | US$188.39 | PB20.1x | E1.2% | 4.7% | Real Estate | ||
DGE | UK£22.35 | -7.9% | -24.0% | UK£51.7b | UK£26.06 | PE17.3x | E7.0% | 3.7% | Food, Beverage & Tobacco | ||
CNR | CA$148.75 | -2.3% | -14.5% | CA$91.5b | CA$167.90 | PE21x | E8.2% | 2.3% | Transportation | ||
FDX | US$252.41 | -8.2% | 4.2% | US$60.4b | US$320.69 | PE15.7x | E12.8% | 2.2% | Transportation | ||
CPG | UK£27.90 | 1.3% | 29.8% | UK£46.8b | UK£27.34 | PE42.2x | E14.7% | 1.7% | Consumer Services |